Gilgamesh Pharmaceuticals
Dalibor Sames is a Professor of Chemistry at Columbia University, chemist, and neuroscientist. Dalibor is also an inventor on multiple patents in the psychedelic space and an Entrepreneur and co-founder of Kures, exited ATAI at large multiple to investment.
Gilgamesh Pharmaceuticals
Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy.